Article

Assessing the Value of Integrated Evidence Approaches in Drug Development

2024-04-29

Abstract excerpt

<title>Abstract</title> <p>Background The use of Integrated Evidence Packages (IEPs) by the pharmaceutical industry has expanded in recent years with the aim of optimizing healthcare and patient outcomes. The evidence base of IEPs goes beyond traditional randomized controlled trials (RCTs) to provide holistic evidence suitable for all stakeholders. However, this approach to drug development is not systematically...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4c6cdb63-b548-5125-a2f1-e29ecb0d9730
DOI: 10.21203/rs.3.rs-4321838/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessing the Value of Integrated Evidence Approaches in Drug DevelopmentDOI 10.21203/rs.3.rs-4321838/v1Read

The Net Financial Benefits of Single Vendor Integrated CDMO and CRO Drug Development ServicesSemantic proximity Read

The Impact of the Inflation Reduction Act on Investment in Innovative Medicines: A Project- Level AnalysisSemantic proximity Read

Non-commercial pharmaceutical R&D: what do neglected diseases suggest about costs and efficiency?Semantic proximity Read

How the HTAR will contribute to a value-based decision making for medicinal products across the EUSemantic proximity Read

Generative Mechanisms Influencing Economic Decision Making in Digital Therapeutics DevelopmentSemantic proximity Read

Quantifying the Dual Value and Governance Risks of Early Access Programs in Oncology: A Single-Centre Analysis and National Policy FrameworkSemantic proximity Read

Social and private value created through commercialization of Gilead Sciences’ innovative medicines for Hepatitis C and HIV: a cross-sectional analysisSemantic proximity Read

Financial Feasibility Study and policy recommendations of Incremental Modified Drugs Development by the Domestic Pharmaceutical IndustrySemantic proximity Read

Features, process and methods of early health technology assessment to inform developers of health technologies : a proposed framework and application to diagnostic technologiesSemantic proximity Read

Pharmaceutical Drug Lifecycle: A Comprehensive Scientific Review of Research and Development Phases, Attrition Rates, and Global DisparitiesSemantic proximity Read

U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Semantic proximity Read

“A Process-Based Approach to Conflicts of Interest”Semantic proximity Read